Topic
Welcome
Pharma Strategy: Sustainable growth by delivering more patient benefits at reduced cost to society
Commercial Opportunities: Near-term growth drivers
Late Stage Pipeline Oncology & Non-malignant Hematology
Late Stage Pipeline Neuroscience & Immunology
Late Stage Pipeline Ophthalmology
Late Stage Pipeline Infectious Diseases
Presenter
Karl Mahler, Head of Investor Relations
Bill Anderson, Chief Executive Officer Roche Pharmaceuticals
Teresa Graham, Head of Pharma Global Product Strategy
Levi Garraway, Chief Medical Officer and Head Global Product Development
Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases, Clinical Development
Nilesh Mehta, Life Cycle Leader Faricimab
Barry Clinch, Global Head Infectious Diseases, Clinical Development